Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INTERFERON BETA-1A Cause Extra dose administered? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Extra dose administered have been filed in association with INTERFERON BETA-1A (Avonex). This represents 0.0% of all adverse event reports for INTERFERON BETA-1A.

15
Reports of Extra dose administered with INTERFERON BETA-1A
0.0%
of all INTERFERON BETA-1A reports
0
Deaths
3
Hospitalizations

How Dangerous Is Extra dose administered From INTERFERON BETA-1A?

Of the 15 reports, 3 (20.0%) required hospitalization.

Is Extra dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1A. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does INTERFERON BETA-1A Cause?

Multiple sclerosis relapse (5,931) Influenza like illness (4,475) Memory impairment (3,468) Multiple sclerosis (3,412) Fatigue (3,164) Fall (3,128) Gait disturbance (3,031) Death (2,766) Pain (2,692) Headache (2,533)

What Other Drugs Cause Extra dose administered?

TIRZEPATIDE (6,774) DULAGLUTIDE (3,047) LORATADINE (1,556) DUPILUMAB (1,422) FEXOFENADINE (1,413) NAPROXEN (908) POLYETHYLENE GLYCOL 3350 (589) ACETAMINOPHEN (552) DALFAMPRIDINE (519) FLUTICASONE\SALMETEROL (499)

Which INTERFERON BETA-1A Alternatives Have Lower Extra dose administered Risk?

INTERFERON BETA-1A vs INTERFERON BETA-1B INTERFERON BETA-1A vs INTERFERON GAMMA INTERFERON BETA-1A vs INTERFERON GAMMA-1B INTERFERON BETA-1A vs INVEGA INTERFERON BETA-1A vs INVEGA SUSTENNA

Related Pages

INTERFERON BETA-1A Full Profile All Extra dose administered Reports All Drugs Causing Extra dose administered INTERFERON BETA-1A Demographics